Neogen Future Growth
Future criteria checks 3/6
Neogen is forecast to grow earnings and revenue by 106.9% and 4.6% per annum respectively while EPS is expected to grow by 106.2% per annum.
Key information
106.9%
Earnings growth rate
106.2%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 4.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Oct 2024 |
Recent future growth updates
Recent updates
Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?
Nov 07Neogen Stock: Expect Volatility To Continue Amid Weak Growth
Oct 11Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)
Aug 28We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt
Jul 31Neogen Corporation: Challenges Remain
Jun 26There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
5/31/2027 | 1,032 | 39 | N/A | N/A | 2 |
5/31/2026 | 984 | 20 | N/A | N/A | 2 |
5/31/2025 | 936 | -2 | N/A | N/A | 2 |
8/31/2024 | 912 | -24 | -125 | -6 | N/A |
5/31/2024 | 924 | -9 | -76 | 35 | N/A |
2/29/2024 | 929 | 2 | -13 | 99 | N/A |
11/30/2023 | 919 | 12 | 17 | 113 | N/A |
8/31/2023 | 919 | -27 | -5 | 78 | N/A |
5/31/2023 | 822 | -23 | -25 | 41 | N/A |
2/28/2023 | 721 | -13 | -82 | -30 | N/A |
11/30/2022 | 631 | -16 | -50 | -6 | N/A |
8/31/2022 | 531 | 36 | -5 | 31 | N/A |
5/31/2022 | 527 | 48 | 44 | 68 | N/A |
2/28/2022 | 514 | 49 | 50 | 70 | N/A |
11/30/2021 | 503 | 57 | 54 | 75 | N/A |
8/31/2021 | 487 | 62 | 55 | 79 | N/A |
5/31/2021 | 468 | 61 | 54 | 81 | N/A |
2/28/2021 | 450 | 61 | 58 | 85 | N/A |
11/30/2020 | 433 | 60 | 71 | 93 | N/A |
8/31/2020 | 426 | 61 | 65 | 87 | N/A |
5/31/2020 | 418 | 59 | 62 | 86 | N/A |
2/29/2020 | 419 | 59 | 62 | 81 | N/A |
11/30/2019 | 417 | 60 | 51 | 72 | N/A |
8/31/2019 | 416 | 60 | 52 | 71 | N/A |
5/31/2019 | 414 | 60 | 49 | 64 | N/A |
2/28/2019 | 413 | 62 | 49 | 66 | N/A |
11/30/2018 | 410 | 65 | 57 | 74 | N/A |
8/31/2018 | 403 | 66 | 48 | 67 | N/A |
5/31/2018 | 398 | 63 | N/A | 69 | N/A |
2/28/2018 | 389 | 58 | N/A | 62 | N/A |
11/30/2017 | 382 | 52 | N/A | 58 | N/A |
8/31/2017 | 372 | 46 | N/A | 59 | N/A |
5/31/2017 | 358 | 44 | N/A | 60 | N/A |
2/28/2017 | 353 | 41 | N/A | 53 | N/A |
11/30/2016 | 341 | 39 | N/A | 44 | N/A |
8/31/2016 | 330 | 37 | N/A | 49 | N/A |
5/31/2016 | 321 | 37 | N/A | 35 | N/A |
2/29/2016 | 310 | 36 | N/A | 38 | N/A |
11/30/2015 | 301 | 35 | N/A | 41 | N/A |
8/31/2015 | 290 | 34 | N/A | 40 | N/A |
5/31/2015 | 283 | 34 | N/A | 44 | N/A |
2/28/2015 | 272 | 32 | N/A | 38 | N/A |
11/30/2014 | 265 | 31 | N/A | 34 | N/A |
8/31/2014 | 256 | 29 | N/A | 27 | N/A |
5/31/2014 | 247 | 28 | N/A | 22 | N/A |
2/28/2014 | 236 | 28 | N/A | 24 | N/A |
11/30/2013 | 225 | 28 | N/A | 26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEOG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: NEOG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NEOG is expected to become profitable in the next 3 years.
Revenue vs Market: NEOG's revenue (4.6% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: NEOG's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NEOG's Return on Equity is forecast to be high in 3 years time